Navigation Links
Paradigm shift: Switch for programmed cell death promotes spread of glioblastoma
Date:3/11/2008

ugh the network of interwoven protein fibers that separate different tissue layers of the body from each other. With the aid of these protein scissors, tumor cells invade healthy tissue and form the dangerous protrusions that penetrate deep into the brain tissue.

The result showed the scientists a way how to stop the invasion of glioblastoma: They treated mice that had been transplanted glioblastoma with an antibody that blocks CD95. As a result, the migration of cancer cells ceded.

This is almost a paradigm shift, says Ana Martin-Villalba. Up to now, the goal has been to promote formation of CD95 and CD95L in tumor cells. In the case of glioblastoma, we now have to warn against this approach: This would only additionally support the spread of the tumor. The goal is rather to block activation of CD95. However, it is currently not possible to investigate this treatment approach in humans, because a useable antibody against human CD95 protein is not yet available.


'/>"/>

Contact: Dr. Sibylle Kohlstdt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Paradigm Selects Jopari to Provide E-Billing Gateway for Customers
2. Schizophrenia Gene May Have On/Off Switch
3. Brain Switch Helps Doctors Deal With Patients Pain
4. Switching to MA Coverage Unlikely for Current Beneficiaries With MediGap or Medicare Only
5. Scientists Spot Eye Development Switch
6. A molecular switch is linked to a common breast cancer
7. Researchers identify unusual molecular switch for common form of advanced breast cancer
8. Cell Structure Helps Direct Cancer Gene Switch
9. Childrens Hospital researchers identify molecular switch that could save very young lives
10. Protein-dependent switch regulates intracellular trafficking in epithelial cells
11. Switch for Internal Body Clock Found
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
(Date:7/25/2008)... Whether you are an Olympian, Profe... there are Five Things You Need to Know about Hydr...C. Spine and Sports Center , ...- America,s premier athletes are heading to Beijin...g and sacrifice in the hopes of capturing an Olymp...
Breaking Medicine News(10 mins):Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...y increase a person’s risk of developing dementia ...e effect.// In a recent study conducted, researche...n 20 years. They found those who were obese in mid...dementia later in life. Also, patients who had hig...
...s toll on active baby boomers. Arthritis followed ...//for many of the 78 million middle-aged Americans... ahead. Michael Baroli is finally back on his feet... directing. His glamour photography business depen...
...cancer diagnosed among men in the United States --...e several // treatment options, but new research s...ogether. Doctors hope that the drug -- finasteri...ng prostate cancer. In smaller doses, it’s commonl...
... a way to diagnose melancholic depression using an.../ levels of certain substances in the brain. Melan...arked by insomnia, loss of appetite, and loss of p...evels of the inhibitory transmitter GABA and high ...
Other Medicine News:
(Date:7/24/2008)... WASHINGTON, July 24 /PRNewswire-USNewswire/ --...t" do not tell the whole story. The small scale,p...d online in Human,Reproduction, is based on recoll... containing soyfoods. "This study is confounded by...ewed with a great deal of,caution," warned Dr. Tam...
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswire-...ay announced the top-line results from the 52-week...llowing the completion of,the 301 phase 3 study fo...safety findings and efficacy was maintained for th...he patients, global assessment scale. In,addition,...
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ --... of Justice:, Chairman Conyers, Ranking Member Sm...he opportunity to testify today., Since I appeare...ave,become even better acquainted with the talente...tment and with the work they do, and I have come t...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 1New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 3Nicotine addiction slashed in test of new cigarette smoking strategy 6279 1Nicotine addiction slashed in test of new cigarette smoking strategy 6279 2Nicotine addiction slashed in test of new cigarette smoking strategy 6279 3Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 1Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 2Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 1Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 2Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 4
...%; mso-hyphenate: none">,BUDAPEST, Hungary, June, ...ands of patients with cancer from suffering,unnece...gress of,the European Association for Palliative C...ted whether this first in class novel,formulation ...duration of effect, mirroring the breakthrough pai...
...IMPAX Laboratories,Inc. (OTC:IPXL) today announce...company,s compound, IPX054, a combined immediate-,...oduct to be,marketed as VADOVA(TM), were presented...onal Congress of Parkinson,s Disease and,Movement ... poster,presentations will be available in the Inv...
Other Medicine Technology:Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 2IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 3IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 4
Aegis CheckPoint is an automated, wireless, computerized remote temperature monitoring, recording, logging and alert system for refrigerator, freezer, incubator and water bath to replace chart record
This requiring no water for use, it provides convenient, long-lasting hand hygiene to physically clean hands when routine hand washing is either not an option or is not convenient. Hibistat allows yo
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri
Exidine® 2% CHG Brushless Surgical Scrub offers exceptional persistence and broad-spectrum antimicrobial activity.
Medicine Products: